Skip to main content
Log in

Medicinal Product Safety on the UK Market — A Ten Year study

  • Abstract
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hass AE, Portale DE, Gorssman RE. 1984 New drug introductions, discontinuations and safety issues in the United Sates and the United Kingdom 1960-1982. Office of Planning and Evaluation, FDA, Washington

    Google Scholar 

  2. Bakke OM, Wardell WM, Lasagna L. Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safety. Clin Pharmacol Ther 1984; 35(5): 559–67

    Article  PubMed  CAS  Google Scholar 

  3. Hass AE, Portale DE, Gorssman RE. New drugs: their market life and safety. Pharm J 1985 Feb; 23: 235–8

    Google Scholar 

  4. Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 286(17): 2215–20

    Article  Google Scholar 

  5. Gray JAM. Evidence based healthcare. Churchill Livingstone, London, 1997: pp72–4

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tang, A., Layton, D., Shakir, S. et al. Medicinal Product Safety on the UK Market — A Ten Year study. Drug-Safety 31, 885 (2008). https://doi.org/10.2165/00002018-200831100-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831100-00012

Keywords

Navigation